What exactly goes on down in radiation oncology? In this episode, we aim to give listeners a better understanding of what radiation therapy is, how it’s given, and what to expect. Dr. Amir Zahra spends the morning with us answering your most common questions.
Between the talks of treatment, surgery and radiation, the mind and spirit can get overwhelmed. In this episode we focus on the mental health of an oncology patient, their family, and their caregivers. Tune in as Lori Wingerter, Nebraska Cancer Specialists Licensed Mental Health Practitioner, discusses talking to kids about cancer, keeping an optimistic attitude, and reclaiming your life after a cancer diagnosis.
It is hard to meet anyone who hasn’t been touched by breast cancer. Statistics say one in eight women will develop the disease in their lifetime. The good news is the survival rates are nearly 100% if the cancer is detected early. But there is a long journey between diagnosis and cure. That’s where this conversation hopes to shed light to anyone who will face it or support someone trying to survive it.
Dr. Kirsten Leu, Medical Oncologist with Nebraska Cancer Specialists, was interviewed for this podcast by Carol Wang, Executive Director of Metro Omaha Medical Society.
We all know someone who has been diagnosed with prostate cancer. But do we know why it’s happening and what do about it? Dr. Ralph Hauke, Medical Oncologists with Nebraska Cancer Specialists, sits down to answer our questions and provide some insight about the diagnosis.
In this episode of In the Know, Dr. Tim Huyck, Medical Oncologist with Nebraska Cancer Specialists discusses the latest in colorectal cancer including screening, staging, and treatment. Learn more about risk factors, genetics, and prevention.
The Power of Immunotherapy! Dr. Joel Michalski, Medical Oncologist with Nebraska Cancer Specialists stops by to touch on the relationship between cancer and your immune system, advances of immunotherapy in the modern age, and a little history lesson too! Have you heard of CAR-T cells and checkpoint inhibitors? Find out more here.